This inventor holds 49 USPTO granted patents and 14 published patent applications and 5 EPO patents, primarily in Ocular Therapeutics. Top assignees: Alcon Universal Ltd., Alcon Laboratories, Inc., Alcon, Inc.. Active years: 1997-2015.
Location History:
- Ft. Worth, TX (US) (1998)
- Forth Worth, TX (US) (2001)
- Fort Worth, TX (US) (1997 - 2015)
Company Filing History:
12 out of 71 
11 out of 449 
11 out of 1,300 
Years Active: 1997-2015
Areas of Expertise:
Title: Unveiling the Inventive Journey of Peter G Klimko
Introduction
Peter G Klimko, a prolific inventor hailing from Fort Worth, Texas, has left an indelible mark in the world of patents with a remarkable tally of 49 inventions to his name. His innovative spirit and passion for creating solutions have led to groundbreaking developments in the field of ocular care and treatment.
Latest Patents
Among his latest patents, Peter G Klimko has unveiled two remarkable inventions. The first one, "Topical ocular analgesic agents," delves into the topical ophthalmic use of specific 2,4-diamino-substituted 1,3-triazines for preventing or alleviating ocular pain in patients. Additionally, he has also disclosed a patent for "Superoxide dismutase mimics for the treatment of ocular disorders and diseases," focusing on the use of SOD mimics, particularly Mn(III) salen SOD mimics, for treating conditions such as AMD, DR, and retinal edema.
Career Highlights
Throughout his career, Peter G Klimko has made significant contributions while working with esteemed companies such as Alcon Universal Ltd. and Alcon, Inc. His dedication to advancing ocular care and pharmaceutical compositions has garnered recognition and acclaim within the industry.
Collaborations
During his inventive journey, Peter G Klimko has had the privilege of collaborating with talented individuals such as Mark R Hellberg and Paul W Zinke. Together, they have synergized their expertise and knowledge to push the boundaries of innovation in the realm of ocular health.
Conclusion
In conclusion, Peter G Klimko stands as a visionary inventor whose passion for creating impactful solutions has reshaped the landscape of ocular care. With a rich portfolio of patents and a legacy of collaboration, he continues to inspire and drive forward progress in the field of pharmaceutical inventions.